Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection.

Seftel, Matthew D

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection.

Seftel, Matthew D.

Seftel MD; Hematologist, University of British Columbia, Vancouver, BC.

CMAJ ; 192(18): E483, 2020 05 04.

Article in English | MEDLINE | ID: covidwho-1686126

Subject(s)

Azithromycin; Hydroxychloroquine; Betacoronavirus; COVID-19; Chloroquine; Coronavirus Infections; Pandemics; Pneumonia, Viral; SARS-CoV-2

Fulltext

Print

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Azithromycin / Hydroxychloroquine Language: English Journal: CMAJ Journal subject: Medicine Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

Print

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Azithromycin / Hydroxychloroquine Language: English Journal: CMAJ Journal subject: Medicine Year: 2020 Document Type: Article